Ascendis Pharma A/S Restricted Cash And Cash Equivalents
Ascendis Pharma A/S (ASND) had Restricted Cash And Cash Equivalents of EUR 5.78 million as of 2019-12-31, per its 20-F filed 2020-04-03.
Discontinued › Notes
ifrs-full:RestrictedCashAndCashEquivalents · last filed 2020-04-03
- 2019-12-31: Restricted Cash And Cash Equivalents 5.78M EUR.
- 2019-09-30: Restricted Cash And Cash Equivalents 5.93M EUR.
- 2019-06-30: Restricted Cash And Cash Equivalents 7.06M EUR.
- 2019-03-31: Restricted Cash And Cash Equivalents 5.67M EUR.
| Period end | Restricted Cash And Cash Equivalents |
|---|---|
| 2019-12-31 | 5.78M EUR 20-F · filed 2020-04-03 |
| 2019-09-30 | 5.93M EUR 6-K · filed 2019-11-18 |
| 2019-06-30 | 7.06M EUR 6-K · filed 2019-08-28 |
| 2019-03-31 | 5.67M EUR 6-K · filed 2019-05-30 |
| 2018-12-31 | 5.57M EUR 20-F · filed 2020-04-03 |
| 2018-09-30 | 5.51M EUR 6-K · filed 2019-11-18 |
| 2018-06-30 | 5.47M EUR 6-K · filed 2019-08-28 |
| 2018-03-31 | 5.14M EUR 6-K · filed 2019-05-30 |
| 2017-12-31 | 63.00K EUR 20-F · filed 2020-04-03 |
| 2017-09-30 | 0.00 EUR 6-K · filed 2018-11-28 |
| 2017-03-31 | 63.00K EUR 6-K · filed 2018-05-30 |